








accepted November 26, 2013.
Journal of the American College of Cardiology Vol. 63, No. 18, 2014
 2014 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00





Silvio Quick, MD, Uwe Speiser, MD, Ruth H. Strasser, MD, PHD, Karim Ibrahim, MD
Dresden, Germany74-year-old man was admitted to our department with a 2-week history of increasingAshortness of breath. A transesophageal echocardiography (TOE) revealed a symptomaticand severe mitral valve stenosis with unusual valve leaﬂet thickening (arrows, mid-TOE
2 chamber view of the prosthetic mitral valve in systole [A] and diastole [B], 3-dimensional
TOE in diastole [C], Online Videos 1 and 2). Three months prior he had undergone a trans-
catheter mitral valve-in-valve implantation with an Edwards SAPIEN XT 29 mm valve (Edwards
Lifesciences Corporation, Irvine, California) and was discharged on a dual antiplatelet therapy.
The main differential diagnosis included a thrombosis of the transcatheter mitral valve-in-valve
implantation or deformation of the mitral valve stent. The latter could be ruled out by cine-
ﬂuoroscopy showing neither gross geometric distortion nor decrease in diameter of the valve at the
level of the annulus (Online Videos 3 and 4, cineﬂuoroscopy of prosthetic mitral valve). On
empirical antithrombotic treatment we saw a signiﬁcantly decreased transvalvular gradient and
signiﬁcant regression of the leaﬂets thickening conﬁrming the diagnosis of bioprosthetic throm-
bosis (mid-TOE 2 chamber view of the prosthetic mitral valve in systole [D] and diastole [E],
3-dimensional TOE in diastole [F], Online Videos 5 and 6). LA ¼ left atrium.
